HALOZYME THERAPEUTICS INC
HALO·40637H109·US·Common Stock·Healthcare - Biotechnology-13D/G
HALO (HALOZYME THERAPEUTICS INC) is held by 234 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($857.3M), VANGUARD CAPITAL MANAGEMENT LLC ($340.7M), VANGUARD PORTFOLIO MANAGEMENT LLC ($339.3M). Net institutional sentiment: Mixed. In Q1 2026, 1 member of Congress and 128 funds bought HALO.
234
Holders
(21 Elite)
$6.7B
Total Value
53% (242)
Consensus
128 buying - 114 selling
13F: Insider & Congress:
Who's Trading
InsiderPLPosard Matthew L.Vest 4K shMay 5, 2026
InsiderCBConnaughton BernadetteVest 7K shMay 5, 2026
InsiderHWHenderson Jeffrey WilliamVest 4K shMay 5, 2026
InsiderDGDUNCAN BARBARA GAYLEVest 4K shMay 5, 2026
InsiderKMKrishnan MaheshVest 4K shMay 5, 2026
Top Holders
Showing 1-20 of 252
1 / 13
Continue exploring
Other Healthcare stocks held by institutions
413 holders · $666.6B
413 holders · $186.3B
394 holders · $391.3B
392 holders · $97B
391 holders · $123.5B
391 holders · $147B
389 holders · $76.8B
385 holders · $208.9B
381 holders · $254.9B
380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer